Literature DB >> 20951453

Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy.

Lucyna Kepka1, Krzysztof Bujko, Tadeusz M Orlowski, Robert Jagiello, Andrzej Salata, Miroslawa Matecka-Nowak, Henryk Janowski, Danuta Rogowska.   

Abstract

AIM: To prospectively assess the cardiopulmonary morbidity and quality of life in patients with non-small cell lung cancer (NSCLC) treated with postoperative radiotherapy (PORT) in comparison to those not receiving PORT.
MATERIALS AND METHODS: From 2003 to 2007, 291 patients entered the study; 171 pN2 patients received 3D-planned PORT (PORT group), 120 pN1 patients (non-PORT group) did not. One month after surgery, all patients completed EORTC QLQ C-30 questionnaire and had pulmonary function tests (PFT); cardiopulmonary symptoms were assessed by modified LENT-SOM scale. Two years later, disease-free patients repeated the same examinations. The differences between baseline values and values recorded at two years in QLQ, LENT-SOM and the PFT of the two groups were compared.
RESULTS: In the whole cohort, the rate of non-cancer related deaths was 5.3% and 5.0% in PORT and non-PORT group, respectively. Ninety-five patients (47 - PORT group, 48 - non-PORT group) were included into the final analysis. The differences in the QLQ and cardiopulmonary function (LENT/SOM, PFT) between both groups were insignificant. The forced expiratory volume in one second was on average 12.2% and 1.3% better in the PORT and the non-PORT group, respectively, p=0.2.
CONCLUSIONS: Our findings support the hypothesis about insignificant morbidity of 3D-planned PORT.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20951453     DOI: 10.1016/j.radonc.2010.09.020

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

Review 1.  Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Uğur Selek; Yasemin Bölükbaşı; James W Welsh; Erkan Topkan
Journal:  Balkan Med J       Date:  2014-09-13       Impact factor: 2.021

Review 2.  Radiotherapy for single station N2 NSCLC.

Authors:  Jan P van Meerbeeck
Journal:  Transl Lung Cancer Res       Date:  2014-08

3.  Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy.

Authors:  Paolo Borghetti; Fernando Barbera; Marco Lorenzo Bonù; Francesca Trevisan; Stefano Ciccarelli; Paola Vitali; Marta Maddalo; Luca Triggiani; Nadia Pasinetti; Sara Pedretti; Bartolomea Bonetti; Gianluca Pariscenti; Andrea Tironi; Alberto Caprioli; Michela Buglione; Stefano Maria Magrini
Journal:  Radiol Med       Date:  2016-05-26       Impact factor: 3.469

Review 4.  Proton therapy for post-operative radiation therapy of non-small cell lung cancer.

Authors:  Annemarie Fernandes Shepherd
Journal:  Transl Lung Cancer Res       Date:  2018-04

5.  Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.

Authors:  Jose Luis Lopez Guerra; Daniel Gomez; Yan Zhuang; Lawrence B Levy; George Eapen; Hongmei Liu; Radhe Mohan; Ritsuko Komaki; James D Cox; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-08-01       Impact factor: 7.038

Review 6.  Evidence-based recommendations of postoperative radiotherapy in lung cancer from Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).

Authors:  A Gómez; J A González; F Couñago; C Vallejo; F Casas; N Rodríguez de Dios
Journal:  Clin Transl Oncol       Date:  2015-08-18       Impact factor: 3.405

7.  Sequencing postoperative radiotherapy and adjuvant chemotherapy in non-small cell lung cancer: unanswered questions on the not evidence-based approach.

Authors:  Lucyna Kepka; Joanna Socha; Monika Rucinska; Ewa Wasilewska-Tesluk; Katarzyna Komosinska
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

8.  Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer.

Authors:  Xuquan Jing; Xue Meng; Xindong Sun; Jinming Yu
Journal:  Onco Targets Ther       Date:  2016-02-19       Impact factor: 4.147

Review 9.  Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer.

Authors:  Cecile Le Péchoux; Olaf Mercier; Deborah Belemsagha; Ryan Bouaita; Benjamin Besse; Elie Fadel
Journal:  EJC Suppl       Date:  2013-09

10.  Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database.

Authors:  Xin Sun; Yu Men; Jianyang Wang; Yongxing Bao; Xu Yang; Maoyuan Zhao; Shuang Sun; Meng Yuan; Zeliang Ma; Zhouguang Hui
Journal:  Thorac Cancer       Date:  2021-03-16       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.